Longitudinal Prediction of Drug Response in High-Grade Serous Ovarian Cancer Organoid Cultures Aligning with Clinical Responses
E. Cavarzerani, I. Caligiuri, M. Bartoletti, G. Corona, T. Perin, A. Palumbo, V. Canzonieri, F. Rizzolio
The paper validates a high-grade serous ovarian cancer organoid platform's ability to predict drug responses over time, showing clinical relevance for targeted therapies.
bioRxiv · May 9, 2024Cancer Biology